Serum Vitamin D3 and Osteocalcin Levels in Iraqi Females with Lupus Erythematosus and their Relationship to Disease Severity

Mohammed Rabie Nasih; Hassan Ali Al-Saadi; Radhwan Mohammed Hussein; Faiq Isho Gorial

doi:10.54133/ajms.v5i.152

Authors

Mohammed Rabie Nasih College of Applied Medical Sciences, University of Kerbala, Kerbala, Iraq https://orcid.org/0009-0000-4193-190X
Hassan Ali Al-Saadi College of Applied Medical Sciences, University of Kerbala, Kerbala, Iraq https://orcid.org/0000-0001-9296-3151
Radhwan Mohammed Hussein College of Pharmacy, University of Ahl Al Bait, Kerbala, Iraq https://orcid.org/0000-0002-2318-8689
Faiq Isho Gorial Department of Rheumatology and Rehabilitation, College of Medicine, University of Baghdad, Baghdad, Iraq https://orcid.org/0000-0002-2760-5566

DOI:

https://doi.org/10.54133/ajms.v5i.152

Keywords:

Osteocalcin, Vitamin-D3, Systemic lupus erythematosus, Blood urea, Serum creatinine, Anti-nuclear antibody

Abstract

Background: Lupus erythematosus (SLE) is a disease that affects two or more joints and is characterized by inflammation, effusion, or pain that lasts at least 30 minutes in the morning. Musculoskeletal involvement is one of the most prevalent signs of SLE and can be present in up to 90% of patients. Objective: To evaluate the serum levels of vitamin D3 (Vit-D3) and osteocalcin (OC) in patients with SLE and their association with disease severity and other biomarkers. Methods: This case-controlled observational study was conducted on 131 women with SLE and 50 healthy individuals over a period of 4 months, from November 2022 until March 2023. All participants were subjected to laboratory investigations, including measurements of CBC, blood urea, serum creatinine, and ANA levels. A consultant doctor carried out clinical examinations to classify disease severity into three categories—inactive, mild, moderate, and severe—according to the Roma Helper program. Results: The levels of Vit-D and OC were significantly decreased in SLE patients, especially in the severe group (p<0.001). OC and Vit-D3 levels were negatively correlated with disease activity, while OC was positively correlated with HB. The results of Vit-D3 were positively correlated with RBC and negatively correlated with HB. Conclusion: Vit-D and OC levels were significantly decreased in females with SLE and negatively correlated with disease activity.

Downloads

Download data is not yet available.

References

Kiriakidou M, Ching CL. Systemic lupus erythematosus. Ann Intern Med. 2020;172(11):Itc81-itc96. doi: 10.7326/AITC202006020. DOI: https://doi.org/10.7326/AITC202006020

Manson JJ, Rahman A. Systemic lupus erythematosus. Orphanet J Rare Dis. 2006;1:6. doi: 10.1186/1750-1172-1-6. DOI: https://doi.org/10.1186/1750-1172-1-6

Ismail Zoair M, Zaki El-Ghannam M, Abd El-Aziz Gaber H, Mohammed Soliman A. Assessment the role of urine osteoprotegerin as a marker in lupus nephritis. Al-Azhar Med J. 2021;50(3):2201-2212. doi: 10.21608/amj.2021.178681 DOI: https://doi.org/10.21608/amj.2021.178681

Kuhn A, Bonsmann G, Anders HJ, Herzer P, Tenbrock K, Schneider M. The diagnosis and Ttreatment of systemic lupus erythematosus. Dtsch Arztebl Int. 2015;112:423-432. doi: 10.3238/arztebl.2015.0423. DOI: https://doi.org/10.3238/arztebl.2015.0423

Carey R, Simmons S, Malherbe M, Jansen van Rensburg BJ, Joubert G. Clinical features of patients with systemic lupus erythematosus (SLE) attending the SLE outpatient clinic at Universitas Hospital in Bloemfontein, South Africa. South Afr Fam Pract. 2008;50(1):68-c. doi: 10.1080/20786204.2008.10873674.

Lisnevskaia L, Murphy G, Isenberg D. Systemic lupus erythematosus. Lancet. 2014;384(9957):1878-1888. doi: 10.1016/S0140-6736(14)60128-8. DOI: https://doi.org/10.1016/S0140-6736(14)60128-8

Sunarya AM, Pramudianti MD, Hadisuparto Y. The Correlation between total alkaline phosphatase and osteocalcin levels in systemic lupus erythematosus patients. Ind J Clin Pathol Med Lab. 2022;28(3):238-243. doi: 10.24293/ijcpml.v28i3.1668. DOI: https://doi.org/10.24293/ijcpml.v28i3.1668

Hlaing TT, Compston JE. Biochemical markers of bone turnover–uses and limitations. Ann Clin Biochem. 2014;51(2):189-202. doi: 10.1177/0004563213515190. DOI: https://doi.org/10.1177/0004563213515190

Patti A, Gennari L, Merlotti D, Dotta F, Nuti R. Endocrine actions of osteocalcin. Int J Endocrinol. 2013;2013. doi: 10.1155/2013/846480. DOI: https://doi.org/10.1155/2013/846480

Baker-lepain JC, Nakamura MC, Shepherd J, von Scheven E. Assessment of bone remodelling in childhood-onset systemic lupus erythematosus. Rheumatology. 2011;50(3):611-619. doi: 10.1093/rheumatology/keq307. DOI: https://doi.org/10.1093/rheumatology/keq307

Guo Q, Fan P, Luo J, Wu S, Sun H, He L, et al. Assessment of bone mineral density and bone metabolism in young male adults recently diagnosed with systemic lupus erythematosus in China. Lupus. 2017;26(3):289-293. doi: 10.1177/0961203316664596. DOI: https://doi.org/10.1177/0961203316664596

Institute of Medicine (US) Committee to Review Dietary Reference Intakes for Vitamin D and Calcium; Ross AC, Taylor CL, Yaktine AL, et al., (editors.), Dietary Reference Intakes for Calcium and Vitamin D. Washington (DC): National Academies Press (US); 2011. Available from: https://www.ncbi.nlm.nih.gov/books/NBK56070/ doi: 10.17226/13050 DOI: https://doi.org/10.17226/13050

Hassanalilou T, Khalili L, Ghavamzadeh S, Shokri A, Payahoo L, Bishak YK. Role of vitamin D deficiency in systemic lupus erythematosus incidence and aggravation. Autoimmun Highlights. 2018;9:1-10. doi: 10.1007/s13317-017-0101-x. DOI: https://doi.org/10.1007/s13317-017-0101-x

Dominguez LJ, Farruggia M, Veronese N, Barbagallo M. Vitamin D sources, metabolism, and deficiency: available compounds and guidelines for its treatment. Metabolites. 2021;11(4):255. doi: 10.3390/metabo11040255. DOI: https://doi.org/10.3390/metabo11040255

Carey R, Simmons S, Malherbe M, van Rensburg JJ, Joubert G. Clinical features of systemic lupus erythematosus (SLE) patients attending the SLE outpatient clinic at the Universitas Hospital in Bloemfontein, SA. South Afr Fam Pract. 2008;50(1):68. DOI: https://doi.org/10.1080/20786204.2008.10873674

Ali Y. Rheumatologic tests: a primer for family physicians. Am Fam Physician. 2018;98(3):164-170.

Taha SI, Samaan SF, Ibrahim RA, Moustafa NM, El-Sehsah EM, Youssef MK. Can complete blood count picture tell us more about the activity of rheumatological diseases? Clin Med Insights Arthr Musculoskelet Disord. 2022;15:11795441221089182. doiI: 10.1177/11795441221089182. DOI: https://doi.org/10.1177/11795441221089182

Abira M, Akhter QS. Relationship between CBC and ESR and duration of disease in patients with systemic lupus erythematosus (SLE). J Bangladesh Soc Physiol. 2018;13(2):41-46. doi: 10.3329/jbsp.v13i2.39476 DOI: https://doi.org/10.3329/jbsp.v13i2.39476

Abira M, Akhter QS, Islam MS. Red blood cell distribution width: a promising index for estimating disease activity of Systemic lupus erythematosus. J Bangladesh Soc Physiol. 2021;16(2):95-103. doi: 10.3329/jbsp.v16i2.57570 DOI: https://doi.org/10.3329/jbsp.v16i2.57570

Mohamed OSD, Azmy GJ, Elfadl EMA. Clinical significance of red blood cell distribution width in systemic lupus erythematosus patients. Egypt Rheumatol Rehabil. 2020;47:1-8. doi: 10.1186/s43166-020-00037-y. DOI: https://doi.org/10.1186/s43166-020-00037-y

Shoeib SA, Abd Elhafez MA, Abd El-Hamed AE, Sherief HG. Red blood cell distribution width to estimate lupus activity. Menoufia Med J. 2018;31(2):449.

Tzioufas AG, Kokori SI, Petrovas CI, Moutsopoulos HM. Autoantibodies to human recombinant erythropoietin in patients with systemic lupus erythematosus. Correlation with anemia. Arthritis Rheum. 1997;40(12):2212-2216. doi: 10.1002/art.1780401216. DOI: https://doi.org/10.1002/art.1780401216

Mahowald ML, Dalmasso AP. Lymphocyte destruction by antibody-dependent cellular cytotoxicity mediated in vitro by antibodies in serum from patients with systemic lupus erythematosus. Ann Rheum Dis. 1982;41(6):593-598. doi: 10.1136/ard.41.6.593. DOI: https://doi.org/10.1136/ard.41.6.593

Yuri Gasparyan A, Ayvazyan L, P Mikhailidis D, D Kitas G. Mean platelet volume: a link between thrombosis and inflammation? Curr Pharm Design. 2011;17(1):47-58. doi: 10.2174/138161211795049804. DOI: https://doi.org/10.2174/138161211795049804

Rani B, Suleman M, Sarada C, Manolla ML, Kinnera T, Maccha L, et al. Clinical significance of cystatin C, creatinine, and blood urea in lupus nephritis patients with systemic lupus erythematosus: A South Indian case–control study. Indian J Med Biochem. 2021;25(1):9-13. doi: 10.5005/jp-journals-10054-0172. DOI: https://doi.org/10.5005/jp-journals-10054-0172

Häyry A, Faustini F, Zickert A, Larsson A, Niewold TB, Svenungsson E, et al. Interleukin (IL) 16: a candidate urinary biomarker for proliferative lupus nephritis. Lupus Sci Med. 2022;9(1):e000744. doi: 10.1136/lupus-2022-000744. DOI: https://doi.org/10.1136/lupus-2022-000744

Yang Z, Liang Y, Li C, Xi W, Zhong R. Associations of serum urea, creatinine and uric acid with clinical and laboratory features in patients with systemic lupus erythematosus. Rheumatol Int. 2012;32:2715-2723. doi: 10.1007/s00296-011-1987-7. DOI: https://doi.org/10.1007/s00296-011-1987-7

Palazzo L, Lindblom J, Mohan C, Parodis I. Current insights on biomarkers in lupus nephritis: A systematic review of the literature. J Clin Med. 2022;11(19):5759. doi: 10.3390/jcm11195759. DOI: https://doi.org/10.3390/jcm11195759

Kene K, Wondimnew T, Welde M, Mateos T, Adugna T, Gerema U, et al. Prevalence and determinants of impaired serum creatinine and urea among type 2 diabetic patients of jimma medical center, Jimma, Southwestern Ethiopia, 2019. Endocr Metab Sci. 2021;3:100096. doi: 10.1016/j.endmts.2021.100096. DOI: https://doi.org/10.1016/j.endmts.2021.100096

Bagavant H, Fu SM. Pathogenesis of kidney disease in systemic lupus erythematosus. Curr Opin Rheumatol. 2009;21(5):489-494. doi: 10.1097/BOR.0b013e32832efff1. DOI: https://doi.org/10.1097/BOR.0b013e32832efff1

Souza vad, Bastos MG, Fernandes nmds, Mansur HN, Raposo NRB, Souza dmkd, et al. Association of hypovitaminosis D with systemic lupus erythematosus and inflammation. Brazilian J Nephrol. 2014;36:430-436. doi: 10.5935/0101-2800.20140062. DOI: https://doi.org/10.5935/0101-2800.20140062

Tedeschi SK, Aranow C, Kamen DL, Leboff M, Diamond B, Costenbader KH. Effect of vitamin D on serum markers of bone turnover in SLE in a randomised controlled trial. Lupus Sci Med. 2019;6(1):e000352. doi: 10.1136/lupus-2019-000352. DOI: https://doi.org/10.1136/lupus-2019-000352

Bogaczewicz J, Karczmarewicz E, Pludowski P, Zabek J, Kowalski J, Lukaszkiewicz J, et al. Feasibility of measurement of bone turnover markers in female patients with systemic lupus erythematosus. Revista Brasileira de Reumatologia. 2015;55:133-139. doi: 10.1016/j.rbr.2014.10.004. DOI: https://doi.org/10.1016/j.rbre.2014.10.004

Ducy P. The role of osteocalcin in the endocrine cross-talk between bone remodelling and energy metabolism. Diabetologia. 2011;54(6):1291-1297. doi: 10.1007/s00125-011-2155-z. DOI: https://doi.org/10.1007/s00125-011-2155-z

Giannelou M, Skarlis C, Stamouli A, Antypa E, Moutsopoulos HM, Mavragani CP. Atherosclerosis in SLE: a potential role for serum parathormone levels. Lupus Sci Med. 2020;7(1):e000393. doi: 10.1136/lupus-2020-000393. DOI: https://doi.org/10.1136/lupus-2020-000393

Zhu L, Zhang J, Wang J, Lv X, Pu D, Wang Y, et al. Uncoupled bone remodeling is characteristic of bone damage in premenopausal women with new-onset systemic lupus erythematosus. Lupus. 2021;30(7):1116-1123. doi: 10.1177/09612033211005067. DOI: https://doi.org/10.1177/09612033211005067

Ruiz-Irastorza G, Egurbide M, Olivares N, Martinez-Berriotxoa A, Aguirre C. Vitamin D deficiency in systemic lupus erythematosus: prevalence, predictors and clinical consequences. Rheumatology. 2008;47(6):920-923. doi: 10.1093/rheumatology/ken121. DOI: https://doi.org/10.1093/rheumatology/ken121